News & Articles

The high-throughput system enables laboratories to double or even triple their testing capacity

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

BLENREP is the fifth major medicine approval for GSK in 2020

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response

Ideal for cell and gene therapy and COVID-19 research, BioStore IIIv offers inventory control and reporting capabilities

The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources

Exclusive interviews, new methods, free downloads, and much more to help you advance your work

California Laboratories can now instantly transmit covid-19 data to the CalREDIE system

Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer

Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

Rapid antibody test receives CE mark for use by healthcare professionals